In silico Studies on the Therapeutic Potential of Novel Marker Compounds Isolated from Chemically Modified Bioactive Fraction from Curcuma longa (Non-carbonyl Curcuma longa)
Arshi Naqvi2,3★, Reem A. K. Al‑Harbi2, Samah Ali2,4, Richa Malasoni3, Swati Gupta3, Anil Kumar Dwivedi3★ Corresponding author
- 1Department of Chemistry, College of Science, Taibah University, Al‑Madina Al‑Munawwara, Saudi Arabia.
- 2Pharmaceutics Division, CSIR‑Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
- 3Vitamins, The National Organization for Drug Control and Research, Al‑Agouzah, Giza, Egypt.
CORRESPONDENCE
Arshi Naqvi
Pharmaceutics Division, CSIR‑Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
Received: 31-07-2020; Revised: 23-11-2020; Accepted: 03-12-2020.
Volume 17, Issue 74 · pp. 263–267 · PUBLISHED 12 July 2021 · DOI: 10.4103/pm.pm_317_20
ABSTRACT
Objectives: In the present study, novel marker compounds (A and B) have been successfully isolated from NCCL and their various in silico traits and interactions were studied. Materials and Methods: Marker compounds A and B were characterized utilizing various spectroscopic data (one‑dimensional [1D]/2D Nuclear Magnetic Resonance (NMR), mass spectrometry, and infrared). Isolated compounds were subjected to in silico computational tools for predicting their drug‑likeness, pharmacokinetic, pharmacodynamic properties. Results: Both compounds A and B flaunted drug‑like properties by following the standard descriptors along with good in silico absorption. Conclusion: Novel marker compounds A and B were successfully isolated from NCCL and fully characterized utilizing spectroscopic techniques. Both the compounds displayed good drug‑like properties.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Naqvi, A., Al‑Harbi, R. A. K., Ali, S., Malasoni, R., Gupta, S., & Dwivedi, A. K. (2021). In silico Studies on the Therapeutic Potential of Novel Marker Compounds Isolated from Chemically Modified Bioactive Fraction from Curcuma longa (Non-carbonyl Curcuma longa). Pharmacognosy Magazine, 17(74), 263–267. https://doi.org/10.4103/pm.pm_317_20